X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SUN PHARMA SUVEN LIFE/
SUN PHARMA
 
P/E (TTM) x 16.2 15.3 106.0% View Chart
P/BV x 3.0 3.6 83.7% View Chart
Dividend Yield % 1.2 0.2 584.4%  

Financials

 SUVEN LIFE   SUN PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
SUN PHARMA
Mar-16
SUVEN LIFE/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs3391,201 28.2%   
Low Rs144706 20.4%   
Sales per share (Unadj.) Rs39.2117.5 33.4%  
Earnings per share (Unadj.) Rs7.519.6 38.1%  
Cash flow per share (Unadj.) Rs8.823.8 36.9%  
Dividends per share (Unadj.) Rs2.001.00 200.0%  
Dividend yield (eoy) %0.80.1 789.9%  
Book value per share (Unadj.) Rs49.0130.5 37.5%  
Shares outstanding (eoy) m127.282,406.60 5.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.28.1 75.8%   
Avg P/E ratio x32.448.7 66.5%  
P/CF ratio (eoy) x27.540.1 68.7%  
Price / Book Value ratio x4.97.3 67.4%  
Dividend payout %26.85.1 525.2%   
Avg Mkt Cap Rs m30,7322,294,813 1.3%   
No. of employees `0001.014.7 6.5%   
Total wages/salary Rs m41647,971 0.9%   
Avg. sales/employee Rs Th5,236.119,169.8 27.3%   
Avg. wages/employee Rs Th436.53,253.0 13.4%   
Avg. net profit/employee Rs Th995.53,197.9 31.1%   
INCOME DATA
Net Sales Rs m4,995282,697 1.8%  
Other income Rs m1946,170 3.1%   
Total revenues Rs m5,189288,867 1.8%   
Gross profit Rs m1,23383,239 1.5%  
Depreciation Rs m16710,135 1.6%   
Interest Rs m544,769 1.1%   
Profit before tax Rs m1,20574,505 1.6%   
Minority Interest Rs m0-11,126 0.0%   
Prior Period Items Rs m0-19 0.0%   
Extraordinary Inc (Exp) Rs m0-6,852 0.0%   
Tax Rs m2559,349 2.7%   
Profit after tax Rs m95047,159 2.0%  
Gross profit margin %24.729.4 83.8%  
Effective tax rate %21.212.5 168.7%   
Net profit margin %19.016.7 114.0%  
BALANCE SHEET DATA
Current assets Rs m4,986308,646 1.6%   
Current liabilities Rs m1,042132,477 0.8%   
Net working cap to sales %79.062.3 126.7%  
Current ratio x4.82.3 205.3%  
Inventory Days Days6183 73.5%  
Debtors Days Days3988 44.6%  
Net fixed assets Rs m3,126133,606 2.3%   
Share capital Rs m1272,407 5.3%   
"Free" reserves Rs m3,717266,909 1.4%   
Net worth Rs m6,236314,042 2.0%   
Long term debt Rs m43231,167 1.4%   
Total assets Rs m8,079542,196 1.5%  
Interest coverage x23.216.6 139.7%   
Debt to equity ratio x0.10.1 69.8%  
Sales to assets ratio x0.60.5 118.6%   
Return on assets %12.49.6 129.7%  
Return on equity %15.215.0 101.4%  
Return on capital %18.917.8 106.3%  
Exports to sales %87.514.0 625.1%   
Imports to sales %12.23.1 389.2%   
Exports (fob) Rs m4,37139,572 11.0%   
Imports (cif) Rs m6118,882 6.9%   
Fx inflow Rs m4,66642,171 11.1%   
Fx outflow Rs m94221,583 4.4%   
Net fx Rs m3,72420,588 18.1%   
CASH FLOW
From Operations Rs m92267,694 1.4%  
From Investments Rs m-619-44,549 1.4%  
From Financial Activity Rs m-698-19,243 3.6%  
Net Cashflow Rs m-3963,902 -10.1%  

Share Holding

Indian Promoters % 63.4 63.7 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.1 -  
FIIs % 0.0 23.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 8.3 439.8%  
Shareholders   37,287 133,026 28.0%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 18, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS